Roger s. Mitchell lecture. Chronic obstructive pulmonary disease phenotypes and their clinical relevance - PubMed (original) (raw)
Roger s. Mitchell lecture. Chronic obstructive pulmonary disease phenotypes and their clinical relevance
Bartolome R Celli. Proc Am Thorac Soc. 2006 Aug.
Abstract
Phenotype is defined as the outward physical manifestation of patients with chronic obstructive pulmonary disease (COPD); anything that is part of their observable structure, function, or behavior. As such, for patients with COPD, the time has come to move from a disease expressed solely by the degree of airflow limitation, to a much broader and resourceful characterization of COPD. Recent advances in the detection of specific clinical phenotypes, such as persistent hypoxemia, hyperinflation with inhomogeneous emphysema, frequent exacerbators, and patients with peripheral muscle dysfunction, are resulting in specific forms of approaches to include therapy that are affecting outcomes. Further, the investigation of the differential influence of gender on the development of COPD is finally catching our attention. In the area of basic science, we are beginning to understand different expressions of disease through genomics, proteomics, and metabonomics. Extensions of these findings and that of neglected aspects that may explain the clinical course of certain patients, such as their psychologic background, will certainly increase our understanding and provide more solid scientific rationale to the phenotypic characterization of patients with COPD. Further, such understanding will not only help explain the manifestations and course of the disease in particular patients but also help select for specific therapies. The hope is that, coupled with primary and secondary prevention, we can reverse the current epidemic and we can improve the well-being of patients affected by COPD.
Similar articles
- Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM, Sheen SS, Park JH, Jin UR, Yoo JW, Seo JB, Yoo KH, Lee JH, Kim TH, Lim SY, Yoon HI, Lee JS, Lee SD. Oh YM, et al. Int J Tuberc Lung Dis. 2014 Dec;18(12):1407-14. doi: 10.5588/ijtld.14.0205. Int J Tuberc Lung Dis. 2014. PMID: 25517804 - Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?
Soler-Cataluña JJ, Rodriguez-Roisin R. Soler-Cataluña JJ, et al. COPD. 2010 Aug;7(4):276-84. doi: 10.3109/15412555.2010.496817. COPD. 2010. PMID: 20673037 Review. - Clinical Characterization and Treatment Patterns for the Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease with Severe or Very Severe Airflow Limitation.
Blasi F, Neri L, Centanni S, Falcone F, Di Maria G. Blasi F, et al. COPD. 2017 Feb;14(1):15-22. doi: 10.1080/15412555.2016.1232380. Epub 2016 Nov 8. COPD. 2017. PMID: 27824270 - Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J, Díaz O, Repetto PB, Morales A, Saldías F, Lisboa C. Dreyse J, et al. Int J Chron Obstruct Pulmon Dis. 2015 Mar 10;10:525-33. doi: 10.2147/COPD.S76475. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 25792820 Free PMC article. - [From COPD definitions to COPD phenotypes].
Burgel PR. Burgel PR. Presse Med. 2014 Dec;43(12 Pt 1):1337-43. doi: 10.1016/j.lpm.2014.09.004. Epub 2014 Nov 4. Presse Med. 2014. PMID: 25448122 Review. French.
Cited by
- Heterogeneity of lung mononuclear phagocytes in chronic obstructive pulmonary disease.
Lee JS. Lee JS. J Innate Immun. 2012;4(5-6):489-97. doi: 10.1159/000337434. Epub 2012 May 3. J Innate Immun. 2012. PMID: 22572241 Free PMC article. Review. - Pathological networking: a new approach to understanding COPD.
Sabroe I, Parker LC, Calverley PM, Dower SK, Whyte MK. Sabroe I, et al. Thorax. 2007 Aug;62(8):733-8. doi: 10.1136/thx.2007.077768. Thorax. 2007. PMID: 17687100 Free PMC article. Review. - Efficacy of bronchoscopic lung volume reduction by endobronchial valves in patients with heterogeneous emphysema: report on the first Asian cases.
Park TS, Hong Y, Lee JS, Lee SM, Seo JB, Oh YM, Lee SD, Lee SW. Park TS, et al. J Korean Med Sci. 2014 Oct;29(10):1404-10. doi: 10.3346/jkms.2014.29.10.1404. Epub 2014 Oct 8. J Korean Med Sci. 2014. PMID: 25368495 Free PMC article. - Preventing and managing exacerbations in COPD--critical appraisal of the role of tiotropium.
Tashkin DP. Tashkin DP. Int J Chron Obstruct Pulmon Dis. 2010 Feb 18;5:41-53. doi: 10.2147/copd.s9443. Int J Chron Obstruct Pulmon Dis. 2010. PMID: 20368910 Free PMC article. Review. - Sestrin 2 levels are associated with emphysematous phenotype of COPD.
Angelakis L, Papaioannou AI, Papathanasiou E, Mazioti A, Kallieri M, Papatheodorou G, Patentalakis G, Hillas G, Papiris S, Koulouris N, Loukides S, Bakakos P. Angelakis L, et al. PLoS One. 2022 Aug 30;17(8):e0273652. doi: 10.1371/journal.pone.0273652. eCollection 2022. PLoS One. 2022. PMID: 36040980 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials